ID: ALA4248427

Max Phase: Preclinical

Molecular Formula: C10H19NO3SSi

Molecular Weight: 261.42

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  C[C@H](CS)C(=O)N1C[Si](C)(C)C[C@H]1C(=O)O

Standard InChI:  InChI=1S/C10H19NO3SSi/c1-7(4-15)9(12)11-6-16(2,3)5-8(11)10(13)14/h7-8,15H,4-6H2,1-3H3,(H,13,14)/t7-,8+/m1/s1

Standard InChI Key:  HIELEDJWYDZOEX-SFYZADRCSA-N

Associated Targets(Human)

ACE Tclin Angiotensin-converting enzyme (1423 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 261.42Molecular Weight (Monoisotopic): 261.0855AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Ramesh R, Reddy DS..  (2018)  Quest for Novel Chemical Entities through Incorporation of Silicon in Drug Scaffolds.,  61  (9): [PMID:29039662] [10.1021/acs.jmedchem.7b00718]

Source